Jon Engle is a Managing Director at Newmark, based in the San Diego, California office. Engle specializes in providing life science, tech and healthcare real estate solutions. His unique background in real estate offers clients expertise in construction management, development, lease and sale negotiations, financial analysis, strategic planning, market analysis and real estate economics. Prior to joining Newmark, Engle served as a Vice President at Kidder Mathews.
Partial Client List
- Aardvark Therapeutics
- Anabios
- AnaptysBio (NASDAQ: ANAB)
- Abterra Biosciences
- Pacira BioSciences, Inc. (NASDAQ: PCRXX)
- Drawbridge Health
- DTx Pharma
- Emergent BioSolutions (NYSE:EBSI)
- Explora Biolabs
- Johnson & Johnson - DePuy Synthes
- MBrace Therapeutics
- Novoron Bioscience
- PCI Pharma Services
- South 8 Technologies
- Stemson Therapeutics
- TEVA (NASDAQ: TASE)
- Tempo Therapeutics
- United Therapeutics (NASDAQ: UTHR)
Education
Point Loma Nazarene, Bachelor of Arts in Business Administration with a concentration in entrepreneurial finance.